Carret Asset Management LLC Has $398,000 Stock Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

Carret Asset Management LLC reduced its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 2.8% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 2,933 shares of the financial services provider’s stock after selling 85 shares during the quarter. Carret Asset Management LLC’s holdings in iShares Biotechnology ETF were worth $398,000 as of its most recent SEC filing.

Several other large investors also recently modified their holdings of the stock. International Assets Investment Management LLC acquired a new stake in shares of iShares Biotechnology ETF during the 4th quarter worth $76,425,000. Itau Unibanco Holding S.A. bought a new stake in shares of iShares Biotechnology ETF during the 3rd quarter worth $48,242,000. Miracle Mile Advisors LLC lifted its position in shares of iShares Biotechnology ETF by 0.4% during the 3rd quarter. Miracle Mile Advisors LLC now owns 325,333 shares of the financial services provider’s stock worth $39,785,000 after buying an additional 1,399 shares during the last quarter. Bank Julius Baer & Co. Ltd Zurich lifted its position in shares of iShares Biotechnology ETF by 3.7% during the 3rd quarter. Bank Julius Baer & Co. Ltd Zurich now owns 293,097 shares of the financial services provider’s stock worth $35,843,000 after buying an additional 10,542 shares during the last quarter. Finally, Raymond James Financial Services Advisors Inc. lifted its position in shares of iShares Biotechnology ETF by 8.9% during the 4th quarter. Raymond James Financial Services Advisors Inc. now owns 153,692 shares of the financial services provider’s stock worth $20,879,000 after buying an additional 12,611 shares during the last quarter. 62.45% of the stock is owned by institutional investors and hedge funds.

iShares Biotechnology ETF Price Performance

Shares of IBB stock traded down $2.60 on Thursday, hitting $125.16. 931,714 shares of the company’s stock were exchanged, compared to its average volume of 1,792,658. iShares Biotechnology ETF has a 12 month low of $111.83 and a 12 month high of $141.16. The company has a 50 day moving average of $134.67 and a 200 day moving average of $129.74.

iShares Biotechnology ETF Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, March 27th. Investors of record on Friday, March 22nd were given a dividend of $0.126 per share. The ex-dividend date of this dividend was Thursday, March 21st. This represents a $0.50 annualized dividend and a dividend yield of 0.40%.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.